Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Leflunomide
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Leflunomide 20mg tablets
1001030L0AAABAB
|
Leflunomide | Leflunomide | Musculoskeletal and Joint Diseases | 34,115 |
|
Leflunomide 10mg tablets
1001030L0AAAAAA
|
Leflunomide | Leflunomide | Musculoskeletal and Joint Diseases | 26,934 |
|
Leflunomide 15mg tablets
1001030L0AAADAD
|
Leflunomide | Leflunomide | Musculoskeletal and Joint Diseases | 642 |
|
Arava 20mg tablets
1001030L0BBABAB
|
Arava | Leflunomide | Musculoskeletal and Joint Diseases | 210 |
|
Arava 10mg tablets
1001030L0BBAAAA
|
Arava | Leflunomide | Musculoskeletal and Joint Diseases | 127 |
|
Leflunomide 100mg tablets
1001030L0AAACAC
|
Leflunomide | Leflunomide | Musculoskeletal and Joint Diseases | 1 |
|
Arava 100mg tablets
1001030L0BBACAC
|
Arava | Leflunomide | Musculoskeletal and Joint Diseases | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.